Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs. - Wikidata - awgldk - TriplyDB

Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.

Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.

http://www.wikidata.org/entity/Q38120290

about

Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients.Clinical Application of Pharmacogenetics: Where are We Now?Clinical and ethical considerations of massively parallel sequencing in transplantation science.IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients.Pharmacogenetic considerations in the treatment of Parkinson's disease.Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer.Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients.Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients.Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients.

P2860

Q31097010-0DBD78FB-7BCA-42C8-A3A7-FC3F1F445025 Q36410101-6F891F56-FBA7-476C-8227-919083D843CC Q37155053-3C875FDF-564D-411A-9CB3-BFEA97D2FA6E Q37428559-C5B0AAC5-5B71-46B4-8DC0-214364DB43D8 Q37688773-290E4590-67B2-4E78-B60F-864016F95D06 Q38364825-9BD680A0-DCD7-4921-AACC-AC6EEE3E8888 Q38809767-FA1E7747-640A-456E-9A87-B5DC2C14A266 Q47156375-78B1388C-EEDD-4DCB-83B5-76FA00FE25D5 Q47592664-2F8D626F-C887-4463-A494-933DC401C728 Q49792894-13083E82-EE0C-419B-90E3-6669060B2DD4 Q50462011-883F5463-B732-4217-BD50-B4BF9F55CD39

P2860

Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.

http://www.wikidata.org/entity/Q38120290

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenetics in solid orga ...... cs of immunosuppressive drugs.

@en

type

label

Pharmacogenetics in solid orga ...... cs of immunosuppressive drugs.

@en

prefLabel

Pharmacogenetics in solid orga ...... cs of immunosuppressive drugs.

@en

P1433

Q38120290-CE5C0898-4A2A-4CC0-B17A-7549F355C886

P1476

Q38120290-15D98D96-22B9-447E-883A-62FCDB90CA50

P2093

Q38120290-032D299F-79EE-4FF6-884F-1680F91D382B

Q38120290-10853A9B-0170-4102-B028-7F2857C17BED

P2860

Q38120290-03B749C2-EAF8-4293-B188-E051D95B192D

Q38120290-0579F3D0-CCEE-44DD-89E4-FA20A82B3AB7

Q38120290-0A13A4BD-38CB-46CD-82EE-9E3329283B5D

Q38120290-0ADF6D53-8753-46EB-A920-ED8498EE36C3

Q38120290-0D6A76D3-285E-4A0D-A4D2-AA76E49CC46A

Q38120290-0D83045D-7CC7-4223-9553-A32630B9F846

Q38120290-14AAF60B-1296-4563-B012-2B9D4C97F2BC

Q38120290-1703D101-A448-4F8F-8785-001AB7EABBBA

Q38120290-1F4D39BC-9F2F-4B2A-A93C-5E96A616590F

Q38120290-2034674A-C660-4905-8E41-CAA646DEA263

P304

Q38120290-0FBA45EB-2065-4625-95B4-7FB7E31FEBF7

P31

Q38120290-89ED32BE-F345-4FEE-B0ED-F678988F0201

P356

Q38120290-C7C8B148-9B19-4850-BBB0-5C77877D38AD

P433

Q38120290-E335BBC3-7698-4B01-9458-06922FCAE571

P478

Q38120290-0798422C-ADC4-4076-8324-5B0DDEA3AC49

P577

Q38120290-73C5CEB6-478B-48DA-8B7A-53CCE8B2D4CB

P5875

Q38120290-E74D5B09-84C0-4C4D-8E46-D93ED32AF14D

P698

Q38120290-4815CBD6-0D00-421A-A58E-AF58208FD2BE

P921

Q38120290-59D1405C-9CC8-44C9-85DC-CA1436AE66E0

P356

P1433

Pharmacogenomics

P1476

Pharmacogenetics in solid orga ...... cs of immunosuppressive drugs.

@en

P2093

Marek Droździk

http://www.w3.org/2001/XMLSchema#string

Mateusz Kurzawski

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

A "silent" polymorphism in the MDR1 gene changes substrate specificity

The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation.

Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.

Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study.

Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control.

Association of MDR1 gene SNPs and haplotypes with the tacrolimus dose requirements in Han Chinese liver transplant recipients.

P304

1099-1118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.13.89

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248382858

http://www.w3.org/2001/XMLSchema#string

P698

23837483

http://www.w3.org/2001/XMLSchema#string

P921

organ transplantation